Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2016-12-23
Original SEC Filing: Click here

---

Webplus: SVA/20161223/6-K/2_EX-99.1/000.htm SEC Original: v455706_ex99-1.htm
Sinovac Responds to Recent Report Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China BEIJING, China, December 23, 2016 — Sinovac’s Audit Committee has authorized the commencement of an internal investigation into the allegations made in the report. The Audit Committee has engaged Latham & Watkins as independent counsel to assist with the investigation. Pending the

---

---

Webplus: SVA/20161223/6-K/1/000.htm SEC Original: v455706_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2016-12-23CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD, HAIDIAN DISTRICT
BEIJING 100085